MFN2 and UCP4 play a coregulatory role in numerous disorders, including nonalcoholic fatty liver disease (NAFLD), Parkinson's disease, Alzheimer's disease (AD), and Huntington's disease. This evidence concerns the gene SLC25A27 and metabolic dysfunction-associated steatotic liver disease.